Pathway’s Post

👥 Incorporating #digitaltwins into Phase 3 randomized trials can reduce control arm sizes by up to 33%, cutting costs and speeding up timelines. In a 1,000-patient trial, reducing the control group by 25% can save 4-5 months in enrollment, while a 50% reduction can cut nearly a year off the trial—accelerating development and delivering life-saving treatments faster. Learn more in "How AI-Generated Digital Twins Are Speeding Up Clinical Development" by CEO Steven Herne: https://bit.ly/3ZUEKBd

#GenAI could transform #clinical research in five key ways: 1. Clinical trial design 2. Trial feasibility and site selection 3. Patient recruitment and retention 4. Data analysis 5. Regulatory submission and review. But there are barriers to its full adoption – a new report outlines how private and public sector organizations can collaboration to overcome these barriers and use GenAI to benefit #patients, providers and society as a whole. Find our more in this piece by Daniel Reiss, Associate Principal, ZS and Jitka Kolarova: https://lnkd.in/eiDBMYiC

We're excited to announce QuantHealth's strategic partnership with Atropos Health, utilizing their extensive federated data model to enhance the accuracy and impact of our trial simulations to the point of care. This partnership marks a significant advancement in delivering AI-powered solutions that benefit patients, physicians, and drug developers alike.

I am very proud of our team for accomplishing this. Connecting #RWD to the clinical and operational data we collect enables a stronger understanding of how participants respond to care. Access to medical information isn’t optional - it’s necessary and this provides that pathway towards precision care our industry sorely needs. Let’s go! #patientfirst, #humancentered, #simplybetterdata

🚀 Join the Discussion on Diagnostics Regulation Reform! 🧬 As you know clinical diagnostics shape 70% of healthcare decisions, yet regulatory frameworks are struggling to meet market needs. Congress has put out an RFI (see below) to seek our input. 🔍 Crucial questions US Congress is seeking input on: - FDA's role in diagnostics oversight (ex. LDTs) - Integration of AI in regulatory processes - Streamlining approvals for special populations - Expanding diagnostic settings like point-of-care tests 💡 Our input matters! Submit responses to diagnostics@help.senate.gov by April 3, 2024. Let's shape the future of healthcare together! #DiagnosticsReform #HealthcareInnovation #RegulatoryFramework Original RFI: https://lnkd.in/eiFQ4Ns7

Planning your first clinical trial? Make sure you're thinking ahead! At Simbec-Orion, we understand that demonstrating value early is key. Our partnership with biotx.ai enhances your decision-making process by providing crucial data insights—even at the nonclinical stage. This approach supports your submission strategy and can offer additional value to investors before you even reach dossier authorisation. Ready to optimise your journey? Let's connect! #ClinicalTrials #DrugDevelopment #DataDriven #Biotech #Pharma #Nonclinical

BioPharma Services Inc., our subsidiary, is expanding into late-stage patient trials through the integration of Canadian Phase Onward (CPO). This strategic move positions us as a full-service CRO, offering comprehensive clinical trial solutions from early to late stages. CPO, a dedicated research site within HEALWELL's The Polyclinic Family and Specialty Medicine Facility, brings established infrastructure and a patient-centric approach to the table. But that's not all! We're also leveraging the power of AI from across HEALWELL to revolutionize drug development. BioPharma will integrate capabilities from Khure Health and Pentavere, further enhancing patient identification and disease detection. Learn more about how we're leveraging AI to accelerate drug development and improve patient outcomes: https://lnkd.in/gdcaSC5z #healthcare #clinicaltrials #AI #drugdevelopment #innovation #patientcare

AI is transforming the landscape of clinical trials, revolutionizing how we identify the right patients and improve outcomes. Through advanced algorithms, AI can sift through vast datasets to pinpoint patients who meet specific trial criteria, enhancing the precision of participant selection and reducing the time needed to initiate studies. This targeted approach not only accelerates trial timelines but also increases the likelihood of therapeutic success, directly benefiting patient health and well-being. As AI continues to evolve, its potential to reshape clinical research and deliver more personalized, effective treatments is nothing short of groundbreaking—ushering in a new era of precision medicine and patient-centric care. Explore an insightful article by Brian Buntz that highlights research articulating AI’s impact on clinical trials and their accuracy. #AIinClinicalTrials #PatientOutcomes #CancerCare #PatientExperience #HealthCare

Exciting News from BioPharma Services Inc. 📣 We are thrilled to announce that today, BioPharma Services has been acquired by HEALWELL AI, a leader in innovative AI applications in healthcare technology. HEALWELL AI, with WELL Health Technologies Corp. (TSX: WELL) as its largest shareholder, is renowned for its advanced technologies in early disease diagnosis and personalized treatment. This acquisition allows us to leverage HEALWELL's data science expertise to further improve our service offerings. This acquisition marks a significant milestone in our journey to expand our capabilities and enhance our service offerings within the clinical research industry including research in rare diseases. We want to take a moment to thank Think Research for their invaluable partnership and support over the years. Read the full announcement here: https://hubs.li/Q02BLFML0 For more information about HEALWELL AI, visit their website: https://hubs.li/Q02BLG9Y0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioequivalence, bioavailability, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #biopharma #clinicalresearch #clinicalstudies #clinicaltrials

Speed up clinical trials with #syntheticdata 🚀